| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 12/28/2006 | US20060293375 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
| 12/28/2006 | US20060293353 Matrix metalloproteinase inhibitors |
| 12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/28/2006 | US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293302 For therapy of acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, shock states induced by cytokine therapy (IL-2, TNF), organ transplantation and transplant rejection, head trauma, acute lung injury, ARDS, inflammatory skin conditions such as sunburn, inflammatory eye conditions |
| 12/28/2006 | US20060293297 Cyanofluoropyrrolidine derviative |
| 12/28/2006 | US20060293291 bone formation is desired, such as osteoporosis, as well as autoimmune diseases such as multiple sclerosis, diabetes mellitus and lupus; exhibit pronounced activity in arresting the proliferation of undifferentiated cells; 2-[(3'-methoxymethoxy)propylidene]-19-nor-1 alpha ,25-(OH)2,D3 |
| 12/28/2006 | US20060293252 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 12/28/2006 | US20060292648 Screening for target that disrupts interaction between human osteopontin (OPN) and an alpha 4 integrin; inflammatory diseases |
| 12/28/2006 | US20060292644 Novel tumor-associated marker |
| 12/28/2006 | US20060292140 Humanized immunoglobulin reactive with alpha4beta7 integrin |
| 12/28/2006 | US20060292133 Use of lactobacillus salivarius |
| 12/28/2006 | DE102005017286B3 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer Tetrahydronaphthalene derivatives, processes for their preparation and their use as anti-inflammatories |
| 12/28/2006 | DE102004063910B4 Trisubstituierte Benzopyranone sowie diese enthaltende Pflanzenextrakte und Mittel Trisubstituted benzopyranones and containing these plant extracts and resources |
| 12/28/2006 | CA2633030A1 Intralesional treatment of psoriasis |
| 12/28/2006 | CA2613249A1 Crystals of phenylalanine derivatives, production method thereof and use thereof |
| 12/28/2006 | CA2612865A1 Thiazolopyrimidines for the therapy of hyperalgesic pain conditions |
| 12/28/2006 | CA2612859A1 Coagulation factor iii polymorphisms associated with prediction of subject outcome and response to therapy |
| 12/28/2006 | CA2612773A1 Modulation of sphingosine kinase signalling |
| 12/28/2006 | CA2612644A1 Modulation of sphingosine kinase signalling |
| 12/28/2006 | CA2606084A1 Improved method of treating degenerative spinal disorders |
| 12/27/2006 | EP1736775A1 Novel ligand of g protein coupled receptor protein and use thereof |
| 12/27/2006 | EP1736547A1 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation |
| 12/27/2006 | EP1736545A2 Soluble zcytor 11 cytokine receptors |
| 12/27/2006 | EP1736541A1 Novel galectin 9 modification protein and use thereof |
| 12/27/2006 | EP1736472A1 2-aminopyridine derivative |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1736158A2 Use of 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiologically acceptable salts |
| 12/27/2006 | EP1735332A1 Azacyclosteroid histamine-3 receptor ligands |
| 12/27/2006 | EP1735328A1 Protein c and endothelial protein c receptor polymorphisms as indicators of subject outcome |
| 12/27/2006 | EP1735315A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS |
| 12/27/2006 | EP1735314A1 Pyrazolo[3,4-b]pyridine compound, and its use as a pde4 inhibitor |
| 12/27/2006 | EP1735313A1 Substituted diaza-spiro-[4.5|-decane derivatives and their use as neurokinin antagonists |
| 12/27/2006 | EP1735312A1 Substituted diaza-spiro-[5.5|-undecane derivatives and their use as neurokinin antagonists |
| 12/27/2006 | EP1735311A1 Beta-carbolines useful for treating inflammatory disease |
| 12/27/2006 | EP1735295A1 Antiinflammatory lactones |
| 12/27/2006 | EP1735055A1 Method of reducing c-reactive protein using growth hormone secretagogues |
| 12/27/2006 | EP1734977A1 Medicament for relief of symptoms of joint disorders and inflammatory conditions |
| 12/27/2006 | EP1734962A2 Compositions and methods for modulating gated ion channels |
| 12/27/2006 | EP1734946A2 Method of using punicic acid to enhance immune response and prevent metabolic disorders |
| 12/27/2006 | EP1734945A1 A composition containing a complex comprising a metal ion and a carboxylate ligand having anti-inflammatory activity |
| 12/27/2006 | EP1597260B1 Triazole compounds useful in therapy |
| 12/27/2006 | EP1443925B1 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors |
| 12/27/2006 | EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors |
| 12/27/2006 | EP1406876B1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 12/27/2006 | EP1392276B1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 12/27/2006 | EP1368317B1 Tryptase inhibitors |
| 12/27/2006 | EP1354047B1 Methods for screening compounds that modulate lipid metabolism |
| 12/27/2006 | EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 12/27/2006 | EP1299374B1 Novel non-psychotropic cannabinoids |
| 12/27/2006 | EP1284717B1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/27/2006 | EP1226144B1 Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 12/27/2006 | EP0844875B1 Use of basic l-carnitine and acyl derivatives for lowering ceramide levels |
| 12/27/2006 | CN1886423A Glycoisoforms of adiponectin and uses thereof |
| 12/27/2006 | CN1886389A 喹喔啉化合物 Quinoxaline compounds |
| 12/27/2006 | CN1886375A Piperidine compound and method for producing same |
| 12/27/2006 | CN1886366A Cyclopentyl derivates |
| 12/27/2006 | CN1886141A T-type calcium channel inhibitor |
| 12/27/2006 | CN1884271A Zedoary cyclo-diolefine and its derivatives preparation method and use |
| 12/27/2006 | CN1883698A Health product for resisting inflammation, stopping pain and promoting rehabilitation of articular cartilage |
| 12/27/2006 | CN1883685A Nano Chinese medicinal preparation of 'An Gong Niu Huang Wan' and preparation method thereof |
| 12/27/2006 | CN1883665A Orally administered tablet, capsule, pills with eight ingredients and preparation method thereof |
| 12/27/2006 | CN1883651A Chinese medicinal composition for treating wind-heat cold and preparation method thereof |
| 12/27/2006 | CN1883637A Middle jiao-warming pain-relieving preparatrion and novel preparation method |
| 12/27/2006 | CN1883635A Tendon-relaxing blood circulation-activating capsule and preparation process thereof |
| 12/27/2006 | CN1883630A Oral liquid for treating traumatic injury and method for preparing same |
| 12/27/2006 | CN1883629A Compound Chinese medicinal ointment for regulating yin-yang equilibrium |
| 12/27/2006 | CN1883618A Effective parts of cirald daphne bark, preparation method and application thereof |
| 12/27/2006 | CN1883602A Chinese medicinal preparation for eliminating inflammation and relieving pain and use thereof |
| 12/27/2006 | CN1883592A Gel for treating rheumatism and headache and method for preparing same |
| 12/27/2006 | CN1883591A Chinese medicine for treating scapulohumeral periarthritis |
| 12/27/2006 | CN1883588A Chinese medicinal capsule for treating inflammation |
| 12/27/2006 | CN1883565A Gel for treating rheumatic arthritis and traumatic injury and method for preparing same |
| 12/27/2006 | CN1883564A Chinese medicinal capsule for treating inflammation and preparation process |
| 12/27/2006 | CN1883536A Orally administered cervus and cucumis polypeptide composition and preparation method thereof |
| 12/27/2006 | CN1883516A Pharmaceutical composition of 'Yunnan Baiyao' for replenishing kidney, strengthening waist, resisting inflammation, dissipating stasis and anaesthesia to ease pain |
| 12/27/2006 | CN1883511A Inclusion compound of ants supercritical extracts and preparation process thereof |
| 12/27/2006 | CN1883483A An injection liquid for treating rheumatism |
| 12/27/2006 | CN1883482A Medicament for treating rheumatism |
| 12/27/2006 | CN1883472A Orally disintegrating tablet of ginkgolide and preparation method thereof |
| 12/27/2006 | CN1292001C Nucleus factor-kB p50 subunit antagonist peptide, preparation and application thereof |
| 12/27/2006 | CN1292000C Nucleus factor-kB p65 subunit combination peptide, preparation and application thereof |
| 12/27/2006 | CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 12/27/2006 | CN1291985C Neurotrophin production/secretion promoting agent |
| 12/27/2006 | CN1291984C 2-thio-substituted imidazole derivatives and use therof in pharmaceutical industry |
| 12/27/2006 | CN1291979C Imidazole compounds and their use as adenosine deaminase inhibitors |
| 12/27/2006 | CN1291757C Remedy for inflammatory bowel diseases |
| 12/27/2006 | CN1291750C Swelling pain relieving medicine and its preparing process |
| 12/27/2006 | CN1291736C Pain stopping ointment for traumatic injury |
| 12/27/2006 | CN1291719C Solid dispersion composition |
| 12/26/2006 | US7153968 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease, eosinophilic granuloma, psoriasis and other benign or malignant proliferative skin diseases, endotoxic shock, laminitis in horses, colic in horses, septic shock, ulcerative colitis, Crohn's disease, reperfusion injury |
| 12/26/2006 | US7153963 Phenylalanine derivatives |
| 12/26/2006 | US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 12/26/2006 | US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 12/26/2006 | US7153887 Treatment anti-neutrophil cytoplasmic antibodies-associated vasculitis in a patient resistant to corticosteroid treatment by administering gusperimus or its salt in cycles |
| 12/26/2006 | US7153881 Compounds acting as melanocortin receptor ligands |
| 12/26/2006 | US7153865 N-type calcium channel antagonists for the treatment of pain |
| 12/26/2006 | US7153861 5,6 -Trimethylenepyrimidin-4-one compounds |